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Is Marfan Syndrome Associated With 
Symptomatic Intracranial Aneurysms?
t
J.S.P. van den Berg, MD; M. Limburg, MD} PhD; R.C.M. Hennekam, MD, PhD
Background and Purpose Marfan syndrome is a heritable 
disorder of connective tissue caused by a deficiency of the 
glycoprotein fibrillin. In several publications and neurological 
textbooks, a relationship between Marfan syndrome and intra­
cranial aneurysms has been assumed.
Methods The records of 135 patients classified as having 
Marfan syndrome who visited the Amsterdam Marfan clinic or 
were admitted to the departments of neurology and neurosur­
gery and the records of all patients with a subarachnoid 
hemorrhage or intracranial aneurysm who visited or were 
admitted to the departments of neurology and neurosurgery 
between January 1, 1982, and January 1, 1994, were retrieved. 
The literature was reviewed regarding Marfan syndrome and 
intracranial aneurysms.
Results No patient visiting the Marfan clinic had a symp­
tomatic intracranial aneurysm. No patient with Marfan syn­
drome had been admitted with a ruptured intracranial aneu­
rysm at the departments of neurology or neurosurgery in this
period, while during that period 826 patients with symptomatic 
intracranial aneurysms had been admitted. During follow-up of 
129 of the 135 patients with Marfan syndrome (2850 retrospec­
tive patient observation years and 581 prospective patient 
observation years), none presented a symptomatic intracranial 
aneurysm. The suggested relationship between Marfan syn­
drome and intracranial aneurysms is based mainly on 10 case 
reports. However, the diagnosis of Marfan syndrome is doubt­
ful in several of these reports. Several large studies of patients 
with Marfan syndrome did not mention a ruptured intracranial 
aneurysm as a clinical manifestation.
Conclusions We conclude that there is insufficient evidence 
to presume a relationship between symptomatic intracranial 
aneurysms and Marfan syndrome on the basis of currently 
available data. (Stroke. 1996;27:10-12.)
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M arfan syndrome is an inherited disorder of 
connective tissue characterized by manifesta­
tions of the musculoskeletal, ocular, and 
cardiovascular systems; it occurs with an estimated prev­
alence of 1 in 10 000.1 Marfan syndrome is diagnosed on 
the basis of clinical manifestations that are strictly 
defined.2'3 The cause is a defect in fibrillin, a glycopro­
tein that is a structural component of microfibrils found 
in many tissues.1-4’5 Several textbooks and other publica­
tions have associated Marfan syndrome with intracranial 
aneurysms.6-11 This relationship, if valid, may be of great 
pathogenic and clinical significance. Studies should be 
performed to elucidate the possible roie of fibrillin in the 
pathogenesis of intracranial aneurysms, and screening of 
patients with Marfan syndrome to detect asymptomatic 
intracranial aneurysms might be warranted. Elective 
surgery in unruptured intracranial aneurysms has a low 
mortality and morbidity,12 while mortality of ruptured 
intracranial aneurysms can be as high as 50%.LV15
The purpose of this study was to seek evidence for an 
increased incidence of intracranial aneurysms in patients 
with Marfan syndrome. We examined the prevalence of 
symptomatic intracranial aneurysms in a group of pa­
tients with Marfan syndrome, investigated the incidence
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of symptomatic intracranial aneurysms during follow-up, 
examined the prevalence of Marfan syndrome in pa­
tients with intracranial aneurysms admitted to the de­
partments of neurology and neurosurgery, and reviewed 
the literature of the possible relationship between intra­
cranial aneurysms and Marfan syndrome.
Subjects and Methods
In 1982 an outpatient clinic in Amsterdam was instituted for 
patients with Marfan syndrome and other connective tissue 
disorders (for both children and adults). At the first and 
subsequent visits, all patients are examined by a (pediatric) 
cardiologist, an ophthalmologist, an orthopedic surgeon, and a 
clinical geneticist. Over the years all patients were examined by 
a stable team o f investigators using a standard protocol. From 
1982 to 1986, Marfan syndrome was diagnosed with the use of 
the criteria defined by Pyeritz and McKusick.3 Thereafter, the 
‘‘Berlin nosology” was followed.2 There are no large differences 
between these sets of criteria, and in retrospect we have also 
applied the Berlin criteria to the group of patients seen before 
1986. All patients fulfilled these criteria. The records of all 
patients attending the Marfan clinic between January 1, 1982, 
and January 1, 1994, and classified as having Marfan syndrome 
were retrieved. We collected data on patients’ age, sex, and 
clinical manifestations. During the follow-up period we 
searched for new manifestations of the disease.
In addition, we retrieved the records over the same period of 
all patients with Marfan syndrome who visited or were admit­
ted to the departments of neurology and neurosurgery, both 
inpatients and outpatients.
For the literature review, we performed a Medline search 
using the following key words: Marfan syndrome, intracranial 
aneurysm, connective tissue disorder, and subarachnoid hem­
orrhage. We also followed all references from the articles thus 
found and traced the references on this topic from several 
textbooks.6*8-10’11
van den Berg et at Marfan Syndrome and Intracranial Aneurysms 11
Table 1. Major Presenting Manifestations in 135 
Consecutive Patients With Marfan Syndrome
No. of 
Patients
Skeletal 
Arachnodactyly 
Anterior chest deformity 
Scoliosis
Dolichostenomelia 
Tall stature*
High arched palate 
Hypermobile joints 
Ocular 
Ectopia lentis 
Unilateral 
Bilateral 
Myopia 
Iridodonesis 
Iris transillumination 
Retinal detachment 
Cardiovascular 
Mitral valve prolapse 
Aortic root dilatation 
Dissection of the aorta 
Dissection of the subclavian artery 
Pulmonary 
Spontaneous pneumothorax 
Skin and integument 
Striae distensae 
Inguinal hernia 
Umbilical hernia 
Diaphragmatic hernia 
Nervous system 
Lumbosacral meningocele
*Height >98th percentile.
Results
The patient group comprised 135 patients (63 male 
and 72 female). The mean age at first presentation was
21.1 years, ranging from 1 to 69 years. The presenting 
manifestations of all patients are listed in Table 1. No 
patient with Marfan syndrome had a history of a sub­
arachnoid hemorrhage or had presented symptoms re­
lating to an intracranial aneurysm at the first visit to the 
Marfan clinic.
In 129 patients, with a mean age of 21.3 years, we 
obtained a follow-up (mean follow-up, 4.5 years; range, 
7 months to 12 years). This resulted in a total of 581 
observation years. Complications that developed during 
the follow-up are listed in Table 2. During the follow-up 
6 patients died; in 4 this was caused by a dissection of the 
ascending aorta, and in 2 the cause was unknown.
During follow-up, one patient experienced an intrace­
rebral hemorrhage. The 37-year-old patient was admit-
Table 2. Complications During Follow-up in 129 
Patients With Marfan Syndrome
No. of 
Patients
Surgical correction of extreme aortic dilatation 5
Spontaneous pneumothorax 5
Progression of anterior chest deformity 3
Dissection of ascending aorta 4
Progressive scoliosis 2
Intracerebral hemorrhage 1
Surgical correction of an atrial septum defect II 1
ted for alcohol and barbiturate intoxication. At the age 
of 34 years Marfan syndrome had been diagnosed on the 
basis of an anterior chest deformity, scoliosis, dolicho­
stenomelia, striae distensae, spontaneous pneumotho­
rax, and mitral valve prolapse. During admission he 
became drowsy. A CT scan of the brain showed an 
intracerebral hemorrhage of the left hemisphere. Coag­
ulation tests were normal. Cerebral angiography did not 
reveal an intracranial aneurysm or other vascular 
abnormalities.
In none of the 826 patients admitted to the depart­
ments of neurology or neurosurgery with subarachnoid 
hemorrhage or intracranial aneurysm was the diagnosis 
of Marfan syndrome made.
Our review of the literature revealed 10 cases of 
patients with Marfan syndrome and intracranial aneu­
rysm.16-23 Eight female and 2 male patients were de­
scribed, with a median age of 41.3 years.
Discussion
No symptomatic intracranial aneurysm occurred in 
our population of patients with Marfan syndrome or 
became clinically overt during the follow-up. In our 
population of patients with intracranial aneurysm, 
Marfan syndrome was not diagnosed,
The relationship between Marfan syndrome and in­
tracranial aneurysm, as suggested in the literature/’-11 is 
probably based on several case reports of intracranial 
aneurysm in patients with Marfan syndrome, 16-25 an 
autopsy report of a young woman with Marfan syn­
drome,26 and a family of which several members had 
intracranial aneurysms and one other member had 
Marfan syndrome.27
Ten cases have been reported of patients with Marfan 
syndrome and an intracranial aneurysm.16-25 In all of 
these the diagnosis of Marfan syndrome was based on 
clinical manifestations. However, in some patients these 
manifestations were incompletely mentioned; for exam­
ple, Higashida et al21 reported no manifestations at all, 
and Rose and Pretorius23 only mentioned a medical 
history that revealed repair of an ascending aortic aneu­
rysm and replacement of an aortic valve. The diagnosis 
of Marfan syndrome in some of these patients may be 
questioned. It is well known that Marfan syndrome can 
be erroneously diagnosed, especially in patients with 
homocystinuria28 or Ehlers-Danlos syndrome type IV.29
Ter Berg et al27 described a family in which seven 
members presented with intracranial aneurysms and one 
member with subarachnoid hemorrhage. One other fam­
ily member was said to have Marfan syndrome, without 
further details. The patient with Marfan syndrome un­
derwent cerebral angiography, which disclosed no intra­
cranial aneurysm. Thus, this report provides no further 
evidence for the co-occurrence of intracranial aneurysms 
and Marfan syndrome.
Stehbens et al2ri examined the cerebral arterial forks 
of a 33-year-old woman with Marfan syndrome who died 
of septicemia after cardiac surgery. They found no 
intracranial aneurysms but described atrophic changes 
and a small evaginated pouch supposedly associated with 
early aneurysm formation. No control observations in 
patients without Marfan syndrome were performed, and 
on the basis of this single patient they concluded that the 
development of intracranial aneurysms in patients with 
and without Marfan syndrome was similar.
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In several large series of patients with Marfan syn­
drome with comprehensive descriptions of the clinical 
manifestations, the occurrence of intracranial aneurysms 
is not mentioned.3’3”-32 If there were no intracranial 
aneurysms at presentation, this does not exclude a future 
development of intracranial aneurysms. However, dur­
ing 581 patient observation years no symptomatic intra­
cranial aneurysm developed, while the majority of the 
known complications of Marfan syndrome did occur. Of 
course, we cannot exclude the presence of asymptomatic 
intracranial aneurysms. In autopsy studies unruptured 
intracranial aneurysms are found in 0.8% to 2.0% of 
cases.33'35 Our Marfan patients had an average age of
21.1 years at presentation. We found no evidence of 
intracranial aneurysms during a total retrospective (2850 
years) and prospective follow-up period of 3431 years. 
The 95% confidence limits of these findings are 0 to 
0*001 events per year. In population studies the inci­
dence is approximately 0.001 sub arachnoid hemorrhages 
per year.14-15 This does not refute any correlation be­
tween the two entities blit is certainly not suggestive of a 
strong relation.
At present there is insufficient evidence to postulate 
an association between Marfan syndrome and intracra­
nial aneurysms. Investigations into a possible pathogenic 
role of fibrillin deficiency in the development of intra­
cranial aneurysms are not warranted.
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